1Gandara DR, Vokes E, Green M, et al. Activity of docetaxel in platinum-treated non-small cell lung cancer: results of a phase Ⅱ multicentertrial [J]. J ClinOncol, 2000,18(1):131-135.
2Van Kooten M, Traine G, Cinat G, et al. Single-agent gemcitabine in pretreated patients with non-small cell lung cancer: results of an argentinean multicentre phase Ⅱ trial [J]. Br J Cancer, 1999,81(5) :846-849.
3Crino L, Mosconi AM, Scagliotti GV, et al. Gemcitabine as second-line treatment for advanced non-small cell lung cancer:a phase Ⅱ trial [J]. J Clin Oncol, 1999,17(7):2081-2085.
4Marino P, Pampallona S, Preatoni A, et al. Chemotherapy vs.supportive care in advanced non-small cell lung cancer: results of a meta-analysis of the literature [J]. Chest, 1994,106(3):861-865.
5Grilli R, Oxman AD, Julian JA. Chemotherapy for advanced non-small cell lung cancer: how much benefit is enough?[J]. J Clin Oncol, 1993,11 (10): 1866-1872.
6Smith IE, O'Brien ME, Talbot DC, et al. Duration of chemotherapy in advanced non-small cell lung cancer: a randomized trial of three versus six courses of mitomycin,vinblastine, and cisplatin [J]. J Clin Oncol, 2001,19 (5):1336-1343.
7Schiller JH, Harrington D, Belani CP, et al. Comparison of four chemotherapy regiments for advanced non-small cell lung cancer [J]. N Engl J Med, 2002,346(2):92-98.
8Cullen M, Billingham J, Woodraffe C, et al. Mitomycin,ifosfamide, and cisplatin in unresectable non-small cell lung cancer:effects on survival and quality of life [J]. J Clin Oncol,1999,17(10): 3188-3194.
9Klastersky J, Sculier JP, Bureau G, et al. Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small cell lung cancer [J]. J Clin Oncol, 1989,7(8):1087-1092.
10Crino L, Scagliotti G, Marangolo M, et al. Cisplatingemcitabine combination in advanced non-small cell lung cancer: a phase Ⅱ study [J]. J Clin Oncol, 1997,15(1):297-303.
